Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Hoffmann-La Roche
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Changhai Hospital
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
H. Lee Moffitt Cancer Center and Research Institute
Melanoma Institute Australia
Wake Forest University Health Sciences
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Columbia University
The First Affiliated Hospital of Guangzhou Medical University
Thomas Jefferson University
Washington University School of Medicine
Haydarpasa Numune Training and Research Hospital
National Institutes of Health Clinical Center (CC)
Jagiellonian University
Sichuan Cancer Hospital and Research Institute
Bristol-Myers Squibb
Melanoma and Skin Cancer Trials Limited
Krankenhaus Nordwest
Erasmus Medical Center
University of California, San Francisco
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
UNC Lineberger Comprehensive Cancer Center
Nanchang University
Hospital Universitari de Bellvitge
Nova Scotia Health Authority
Austrian Breast & Colorectal Cancer Study Group
Peking University First Hospital
Hoffmann-La Roche
Columbia University
University of Birmingham
Fujian Medical University
Palleos Healthcare GmbH
First Affiliated Hospital, Sun Yat-Sen University
Emory University
National Cancer Centre, Singapore
Istanbul Medeniyet University
The University of Texas Health Science Center at San Antonio
West China Hospital
Italian Sarcoma Group
Swiss Cancer Institute
National Cancer Institute (NCI)
Goethe University
National Academy of Medical Sciences, Nepal
Universitätsklinikum Hamburg-Eppendorf
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nanfang Hospital, Southern Medical University
Fujian Maternity and Child Health Hospital